Tag: FDA bioequivalence
Batch Variability and Bioequivalence: What Acceptable Limits Really Mean for Generic Drugs
Explains how batch variability affects generic drug approval, why current bioequivalence limits may be flawed, and how new methods like Between-Batch Bioequivalence are improving safety and accuracy.